Art

J-GLOBAL ID：201702260029096681   Reference number：17A0139536

Influence of the C5a-C5a receptor system on breast cancer progression and patient prognosis

乳癌進行と患者予後についてC5a-C5a受容体システムの影響

Author (8)： Imamura Takahisa (Department of Molecular Pathology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan) ,  Yamamoto-Ibusuki Mutsuko (Department of Breast and Endocrine Surgery, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan) ,  Sueta Aiko (Department of Breast and Endocrine Surgery, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan) ,  Kubo Tatsuko (Department of Molecular Pathology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan) ,  Irie Atsushi (Department of Immunogenetics, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan) ,  Kikuchi Ken (Medical Quality Management Center, Kumamoto University Hospital, Kumamoto, Japan) ,  Kariu Toru (Shokei University, Kumamoto, Japan) ,  Iwase Hirotaka (Department of Breast and Endocrine Surgery, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan)
Material： Breast Cancer
Volume： 23  Issue： 6  Page： 876-885  Publication year： Nov. 2016 
JST Material Number： L3971A  ISSN： 1340-6868  Document type： Article
Article type： 原著論文  Country of issue： Germany, Federal Republic of (DEU)  Language： ENGLISH (EN)

Thesaurus term： *breast tumor ,...
Semi thesaurus term： Tumor progression ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=17A0139536&from=J-GLOBAL&jstjournalNo=L3971A") }}

Author keywords (5)： C5a ,  C5a receptor ,  Prognosis ,  Lymph node metastasis ,  Proliferation

JST classification (3)： Chemistry,biochemistry and pathology of tumors(=neoplasms)  (GE02030N) ,  Biochemistry of antigens,antibodies,complements  (ED04020L) ,  Receptors on cell membrane  (EF04030C)

Reference (41)：

• Siegel R, Naishadham MA, Jemal ADV. Cancer statistics, 2013. CA Cancer J Clin. 2013;63:11-30.
• Anderson WF, Rosenberg PS, Prat A, Perou CM, Sherman ME. How many etiological subtypes of BC: two, three, four, or more ? J Natl Cancer Inst. 2014;106(8):dju165. doi:10.1093/jnci/dju165.
• Gucalp A, Traina TA. Triple-negative BC: adjuvant therapeutic options. Chemother Res Prac 2011;696208. doi:10.1155/2011/696208.
• Carey L, Winer E, Viale G, Cameron D, Gianni L. Triple-negative cancer: disease entity or title of convenience? Nat Rev Clin Oncol. 2010;7:683-92.
• Iwase H, Kurebayashi J, Tsuda H, Ohta T, Kurosumi M, et al. Clinicopathological analyses of triple negative breast cancer using surveyance data from the Registration Committee of the Japanese breast cancer society. Breast Cancer. 2010;17:118-24.

Terms in the title (4)： 乳癌 ,  患者予後 ,  C5a ,  C5a受容体